Innoplexus CEO Gunjan Bhardwaj responded to questions from Med Ad News about his company’s study of consumer perceptions of the pharma industry.
According to the consultants at PwC, the top health industry issues of 2018 will be …
With the focus shifting away from the end reporting, companies have continued to invest in systems and processes that manage “upstream” relationships with healthcare providers and consultants, recognizing that the greater compliance risks center around these relationships than on the reported spend itself.
Habit and red tape are not sufficient excuses for life sciences organizations to keep doing things the way they always have.
